SLDB
Solid Biosciences Participate Bmo Biopharma Spotlight Series
Tuesday, March 21, 2023 BiopharmaWatch Research 1 min read Key Takeaway: Solid Biosciences Participate Bmo Biopharma Spotlight Series
Price reaction · baseline $3.68 (2023-03-20 close) · hit after-hours · 1 other SLDB headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+116%
120-day peak, hindsight
Typical move
7.4%
average across 7 past catalysts
Cash runway
~21 mo
Low dilution risk
Lead asset
carmustine
Phase 3 · Lymphoma
Full Press Release Details
Solid Biosciences Participate Bmo Biopharma Spotlight Series.